Salta al contenuto principale
Ricerc@Sapienza
Toggle navigation
Home
Login
Home
Persone
fabio.didomenico@uniroma1.it
Fabio Di Domenico
Professore Ordinario
Struttura:
DIPARTIMENTO DI SCIENZE BIOCHIMICHE "ALESSANDRO ROSSI FANELLI"
E-mail:
fabio.didomenico@uniroma1.it
Pagina istituzionale corsi di laurea
Curriculum Sapienza
Pubblicazioni
Titolo
Pubblicato in
Anno
Potential therapeutic value of the anti-diabetic drug metformin in a mouse model of Rett syndrome: a preclinical study
FENS 2020 virtual forum
2020
Multiple Herpes simplex virus-1 (HSV-1) reactivations induce protein oxidative damage in mouse brain. Novel mechanisms for Alzheimer’s disease progression
MICROORGANISMS
2020
Chronic perk induction promotes alzheimer-like neuropathology in down syndrome: Insights for therapeutic intervention
PROGRESS IN NEUROBIOLOGY
2020
The dysregulation of OGT/OGA cycle mediates Tau and APP neuropathology in down syndrome
NEUROTHERAPEUTICS
2020
Proteomics study of peripheral blood mononuclear cells in down syndrome children
ANTIOXIDANTS
2020
BVR-A deficiency leads to autophagy impairment through the dysregulation of AMPK/mTOR axis in the brain—Implications for neurodegeneration
ANTIOXIDANTS
2020
Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition)
AUTOPHAGY
2020
Biliverdin reductase-A mediates the beneficial effects of intranasal insulin in Alzheimer disease
MOLECULAR NEUROBIOLOGY
2019
Loss of biliverdin reductase-A favors Tau hyper-phosphorylation in Alzheimer's disease
NEUROBIOLOGY OF DISEASE
2019
Reduced biliverdin reductase-a levels are associated with early alterations of insulin signaling in obesity
BIOCHIMICA ET BIOPHYSICA ACTA. MOLECULAR BASIS OF DISEASE
2019
Restoration of aberrant mTOR signaling by intranasal rapamycin reduces oxidative damage: Focus on HNE-modified proteins in a mouse model of down syndrome
REDOX BIOLOGY
2019
Shining a light on defective autophagy by proteomics approaches: implications for neurodegenerative illnesses
EXPERT REVIEW OF PROTEOMICS
2019
Targeting mitochondria in Alzheimer disease: rationale and perspectives
CNS DRUGS
2019
Metformin treatment rescues aberrant mitochondrial activity and oxidative stress status in the brain of female mouse model of Rett syndrome
6th European Conference on Behaviour and Cognition
2019
Early and selective activation and subsequent alterations to the unfolded protein response in down syndrome mouse models
JOURNAL OF ALZHEIMER'S DISEASE
2018
Poly-ubiquitin profile in Alzheimer disease brain
NEUROBIOLOGY OF DISEASE
2018
Proteomic identification of altered protein O-GlcNAcylation in a triple transgenic mouse model of Alzheimer's disease
BIOCHIMICA ET BIOPHYSICA ACTA. MOLECULAR BASIS OF DISEASE
2018
Biliverdin reductase-A impairment links brain insulin resistance with increased Aβ production in an animal model of aging: implications for Alzheimer disease
BIOCHIMICA ET BIOPHYSICA ACTA. MOLECULAR BASIS OF DISEASE
2018
Protein nitration profile of CD3+ lymphocytes from Alzheimer disease patients: novel hints on immunosenescence and biomarker detection
FREE RADICAL BIOLOGY & MEDICINE
2018
Therapeutic potential of rescuing protein O-GlcNAcylation in tau-related pathologies
EXPERT REVIEW OF NEUROTHERAPEUTICS
2018
« prima
< precedente
1
2
3
4
seguente ›
ultima »
Progetti di Ricerca
Deciphering the the interplay between the unfolded protein response and insulin resistance in Down syndrome brain
Inhibition of PERK pathway for the early treatment of Alzheimer Disease-like cognitive decline in Down Syndrome
The sweet link between aberrant brain metabolism and cognitive decline: A novel role for altered protein O-GlcNAcylation.
Deciphering the role of aberrant PERK/NRF2 axis in Down Syndrome
© Università degli Studi di Roma "La Sapienza" - Piazzale Aldo Moro 5, 00185 Roma